Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Staaf, Johan"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shen, Sipeng, Zhang, Ruyang, Guo, Yichen, Loehrer, Elizabeth, Wei, Yongyue, Zhu, Ying, Yuan, Qianyu, Moran, Sebastian, Fleischer, Thomas, Bjaanæs, Maria Moksnes, Karlsson, Anna, Planck, Maria, Staaf, Johan, Helland, Åslaug, Esteller, Manel, Su, Li, Chen, Feng, Christiani, David C.
Publikováno v:
Shen, Sipeng Zhang, Ruyang Guo, Yichen Loehrer, Elizabeth Wei, Yongyue Zhu, Ying Yuan, Qianyu Moran, Sebastian Fleischer, Thomas Bjaanæs, Maria Moksnes Karlsson, Anna Planck, Maria Staaf, Johan Helland, Åslaug Esteller, Manel Su, Li Chen, Feng Christiani, David C. . A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer. Molecular Oncology. 2018, 12(6), 913-924
Molecular Oncology
Molecular Oncology
Externí odkaz:
http://hdl.handle.net/10852/66300
https://www.duo.uio.no/bitstream/handle/10852/66300/4/Shen_et_al-2018-Molecular_Oncology.pdf
https://www.duo.uio.no/bitstream/handle/10852/66300/4/Shen_et_al-2018-Molecular_Oncology.pdf
Autor:
Karlsson A; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Brunnström H; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Pathology, Regional Laboratories Region Skåne, Lund, Sweden., Micke P; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Veerla S; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Mattsson J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., La Fleur L; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Botling J; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Jönsson M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Reuterswärd C; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Planck M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Respiratory Medicine and Allergology, Skåne University Hospital, Lund, Sweden., Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Electronic address: johan.staaf@med.lu.se.
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2017 Aug; Vol. 12 (8), pp. 1257-1267. Date of Electronic Publication: 2017 May 20.
Autor:
Lauss M; Department of Oncology and Pathology, Clinical Sciences, Lund University Hospital, Lund University, Lund, Sweden., Nsengimana J; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Staaf J; Department of Oncology and Pathology, Clinical Sciences, Lund University Hospital, Lund University, Lund, Sweden., Newton-Bishop J; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Jönsson G; Department of Oncology and Pathology, Clinical Sciences, Lund University Hospital, Lund University, Lund, Sweden. Electronic address: goran_b.jonsson@med.lu.se.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2016 Dec; Vol. 136 (12), pp. 2502-2505. Date of Electronic Publication: 2016 Jun 23.
Autor:
Lauss M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden., Haq R; Departments of Dermatology and Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Cirenajwis H; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden., Phung B; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden., Harbst K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden., Staaf J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden., Rosengren F; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden., Holm K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden., Aine M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden., Jirström K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; Department of Clinical Pathology, Skåne University Hospital, Lund, Sweden., Borg Å; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden., Busch C; Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway., Geisler J; Department of Clinical Molecular Biology and Laboratory Sciences, Akershus University Hospital, Lørenskog, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lønning PE; Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway., Ringnér M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden., Howlin J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden., Fisher DE; Departments of Dermatology and Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA., Jönsson G; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden; CREATE Health Strategic Center for Translational Cancer Research, Lund University, Lund, Sweden. Electronic address: Goran_B.Jonsson@med.lu.se.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2015 Jul; Vol. 135 (7), pp. 1820-1828. Date of Electronic Publication: 2015 Feb 23.
Autor:
Staaf J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Harbst K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Lauss M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Ringnér M; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Måsbäck A; Department of Clinical Pathology, Skåne University Hospital, Lund, Sweden., Howlin J; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Jirström K; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Department of Clinical Pathology, Skåne University Hospital, Lund, Sweden., Harland M; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Zebary A; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Palmer JM; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Ingvar C; Department of Dermatology, LUMC, Leiden, The Netherlands., Olsson H; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Newton-Bishop J; Section of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Hansson J; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden., Hayward N; QIMR Berghofer Medical Research Institute, Brisbane, Australia., Gruis N; Department of Dermatology, LUMC, Leiden, The Netherlands., Jönsson G; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. Electronic address: goran_b.jonsson@med.lu.se.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2014 Dec; Vol. 134 (12), pp. 3000-3003. Date of Electronic Publication: 2014 Jul 07.
Autor:
Gustavsson P; Department of Molecular Medicine and Surgery, Center for Molecular Medicine, L8:02, Karolinska University Hospital, Stockholm, Sweden. peter.gustavsson@ki.se, Schoumans J, Staaf J, Borg A, Nordenskjöld M, Annerén G
Publikováno v:
European journal of medical genetics [Eur J Med Genet] 2007 May-Jun; Vol. 50 (3), pp. 237-41. Date of Electronic Publication: 2007 Feb 21.